Summary -

Key Takeaways Explained for a Non-Medical Audience

– The ketogenic diet significantly reduced HbA1c levels in patients with T2DM, indicating improved long-term glucose control.

– Fasting blood glucose levels dropped substantially in participants following a ketogenic diet.

– Fasting insulin levels were notably reduced, pointing to improved insulin sensitivity.

– The ketogenic diet led to significant reductions in body weight and body mass index (BMI), factors linked to better metabolic outcomes.

– Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores decreased, reflecting a reduction in insulin resistance.

– Triglyceride levels were consistently lowered, while HDL cholesterol levels increased, improving overall lipid profiles.

– LDL cholesterol changes were variable across studies, but the total LDL particle count and LDL particle size were not uniformly reported.

– No serious adverse effects were reported across the included studies, supporting the safety of short- to medium-term ketogenic interventions.

– Caloric intake was often lower in ketogenic diet groups, but improvements were not solely attributed to calorie restriction.

– Reduction in carbohydrate intake was the primary driver of metabolic improvements, consistent with the ketogenic mechanism.

– Participants achieved nutritional ketosis, which is associated with metabolic advantages like increased fat oxidation and reduced glycemic variability.

– The diet was well tolerated by most participants, suggesting it can be a sustainable strategy with appropriate support.

– Improved insulin sensitivity and glycemic control may reduce the need for diabetes medications over time.

– Enhanced lipid metabolism on the ketogenic diet may reduce cardiovascular risks commonly elevated in T2DM populations.

– The review supports ketogenic diets as effective therapeutic dietary interventions for T2DM management, especially when conventional strategies fail.